查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
倍他米松乙酸酯市场：按配方、给药途径、应用、年龄组、分销渠道、地区-规模、份额、前景和机会分析，2022-2030 年
市场调查报告书
商品编码
1213854

倍他米松乙酸酯市场：按配方、给药途径、应用、年龄组、分销渠道、地区-规模、份额、前景和机会分析，2022-2030 年

Betamethasone Acetate Market, by Formulation, by Route of Administration, by Application, by Age Group, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 203 Pages | 商品交期: 2-3个工作天内

价格
简介目录

倍他米松乙酸酯是一种醋酸酯，类固醇酯，17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone。 功能上与倍他米松相关。

Betamethasone acetate 是一种长效皮质类固醇，具有抗炎和免疫抑制特性。 它可以通过肠胃外给药来治疗许多疾病，包括自身免疫性疾病，也可以局部用于治疗炎症性皮肤病，包括湿疹。 Betamethasone Sodium Phosphate 和 Betamethasone Acetate Injectable Suspension 也可用于骨骼肌肉或肌腱（神经节）的囊性肿瘤。 Betamethasone Injectable Suspension 用于治疗由各种情况引起的炎症和疼痛。 这些病症包括多发性硬化症、关节炎等。

市场动态

由于醋酸倍他米松用于治疗肾臟疾病等多种疾病，预计肾臟疾病患病率的增加将推动预测期内的市场增长。 例如，2022 年 7 月，美国疾病控制与预防中心 (CDC) 提供的数据估计，到 2020 年美国将有超过 15% 的成年人，即 3700 万人患有慢性肾病 (CKD)。是 同样的数据还发现，CKD 在 65 岁及以上人群 (38%) 中比在 45-64 岁人群 (12%) 和 18-44 岁人群 (6%) 中更常见。

由于 betametha acetate 用于多种医疗条件，例如呼吸系统疾病，预计呼吸系统疾病患病率的增加将在预测期内推动 betametha acetate 的市场增长。 例如，2021 年 8 月，根据世界卫生组织 (WHO) 的数据，到 2020 年将有大约 6500 万人患有中度至重度慢性阻塞性肺疾病 (COPD)，占全球所有死亡人数的 5%（每 10 万人中有 41.9 人死亡）。

这项研究的主要特点

  • 本报告对全球醋酸倍他米松市场进行了深入分析，展示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
  • 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
  • 它还提供关键见解，例如市场促进因素和抑制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
  • 它根据以下参数介绍了全球醋酸倍他米松市场的主要参与者 - 公司亮点、产品组合、主要亮点、财务业绩、战略 本研究涵盖的主要参与者包括 Merck & Co., Inc.、 American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc., Exela Pharma Sciences , LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • 这份报告中的见解应该能让公司的营销人员和管理人员就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。.
  • 本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球醋酸倍他米松市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第 2 章市场展望

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按配方分类
    • 按给药途径划分的市场概况
    • 市场概况：按应用分类
    • 市场概况：按年龄组
    • 市场概况：按分销渠道
    • 市场概况：按地区
  • 连贯机会图 (COM)

第 3 章市场动态、规律及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场吸引力分析
    • 市场机会
  • 产品发布
  • 合併、收购、联合研究
  • 监管准则和合规性
  • 主要发展状况
  • 害虫分析
  • 技术
  • 对 PORTER 的分析
  • 定价分析 (2021)

第 4 章醋酸倍他米鬆的全球市场-冠状病毒 (COVID-19) 大流行的影响

  • 经济影响
  • COVID-19 的流行病学特征
  • 对供需的影响

第 5 章醋酸倍他米鬆的全球市场，按配方，2017-2030

  • 挂液
  • 药膏
  • 凝胶

第 6 章醋酸倍他米鬆的全球市场：按给药途径，2017-2030

  • 肌肉注射
  • 关节内
  • 皮内

第 7 章全球醋酸倍他米松市场应用，2017-2030（百万美元)

  • 呼吸系统疾病
  • 肾臟疾病
  • 消化系统疾病
  • 眼科疾病
  • 皮肤科领域
  • 其他

第 8 章全球醋酸倍他米松市场：按年龄组分类，2017-2030（百万美元)

  • 儿科
  • 年老

第 9 章全球醋酸倍他米松市场：按分销渠道，2017-2030 年（百万美元）

  • 医院药房
  • 零售药房
  • 在线药店

第 10 章全球各地区醋酸倍他米松市场，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第 11 章竞争格局

  • Merck & Co., Inc.
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

第 12 章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5481

Betamethasone acetate is an acetate ester, a steroid ester, a 17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone. It is functionally related to a betamethasone.

Betamethasone acetate is long-acting corticosteroid has anti-inflammatory and immunosuppressive effects. It can be administered parenterally to treat a number of disease states, including autoimmune illnesses, and topically to treat inflammatory skin conditions including eczema. Betamethasone sodium phosphate and betamethasone acetate injectable suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). Betamethasone injectable suspension is used to treat inflammation and pain from a variety of conditions. These conditions include multiple sclerosis, arthritis, and others.

Market Dynamics

The betamethasone acetate is used in various disease conditions such as renal disease, thus the increasing prevalence of renal disease is expected to drive the market growth over the forecast period. For instance, in July 2022, according to data provided by Center of Disease Control and Prevention (CDC), in 2020, more than 15% of the U.S. adults or 37 million people, are estimated to have Chronic Kidney Disease (CKD). Moreover, according to same source CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%).

The betamethasone acetate is used in various disease condition such as respiratory diseases, thus the increasing prevalence of respiratory disease is expected to drive the betamethasone acetate market growth over the forecast period. For instance, in August 2021, according to the World Health Organization (WHO), in 2020 approximately, 65 million people had moderate to severe Chronic Obstructive Pulmonary Diseases (COPD) that accounts for 5% of deaths (41.9 deaths per 100 000 individuals) globally.

Key features of the study:

  • This report provides in-depth analysis of the global betamethasone acetate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global betamethasone acetate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck & Co., Inc., American Regent, Inc., McKesson Medical-Surgical Inc., GNHIndia.com, Lexicon Medical Supply, Medline Industries, Inc., Caspian Tamin Pharmaceutical Co., Sandoz Canada Inc, NorthWestPharmacy.com Inc., Medisca Inc, Exela Pharma Sciences, LLC, Sanofi Pasteur Inc., Sorrento Therapeutics Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global betamethasone acetate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global betamethasone acetate market

Detailed Segmentation:

  • Global Betamethasone Acetate Market, By Formulation:
    • Suspension
    • Ointment
    • Gel
  • Global Betamethasone Acetate Market, By Route of Administration:
    • Intramuscular
    • Intra-articular
    • Intradermal
  • Global Betamethasone Acetate Market By Application:
    • Respiratory Disease
    • Renal Disease
    • Gastrointestinal Disease
    • Ophthalmic Disease
    • Dermatological Disease
    • Others
  • Global Betamethasone Acetate Market By Age Group:
    • Pediatric
    • Geriatric
  • Global Betamethasone Acetate Market By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Betamethasone Acetate Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Merck & Co., Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • American Regent, Inc.
    • McKesson Medical-Surgical Inc.
    • GNHIndia .com
    • Lexicon Medical Supply
    • Medline Industries, Inc.
    • Caspian Tamin Pharmaceutical Co.
    • Sandoz Canada Inc
    • NorthWestPharmacy.com Inc.
    • MEDISCA PHARMACEUTIQUE INC
    • Exela Pharma Sciences, LLC
    • Sanofi Pasteur Inc.
    • Sorrento Therapeutics Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Formulation
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Age Group
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • PORTER's Analysis
  • Pricing Analysis (2021)

4. Global Betamethasone Acetate Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Betamethasone Acetate Market, By Formulation, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ointment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Betamethasone Acetate Market, By Route of Administration, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Intra-articular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Intradermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Betamethasone Acetate Market, By Application, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Renal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gastrointestinal Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Ophthalmic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Dermatological Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Betamethasone Acetate Market, By Age Group, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Betamethasone Acetate Market, By Distribution Channel, 2017 - 2030, (US$ Million

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Betamethasone Acetate Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Merck & Co., Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • American Regent, Inc.
  • McKesson Medical-Surgical Inc.
  • GNHIndia.com
  • Lexicon Medical Supply
  • Medline Industries, Inc.
  • Caspian Tamin Pharmaceutical Co.
  • Sandoz Canada Inc.
  • NorthWestPharmacy.com Inc.
  • Medisca Inc.
  • Exela Pharma Sciences, LLC
  • Sanofi Pasteur Inc.
  • Sorrento Therapeutics Inc.

12. Section

  • Research Methodology
  • About Us